Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
22,288,494
-
Share change
-
-434,206
-
Total reported value
-
$1,770,704,586
-
Put/Call ratio
-
48%
-
Price per share
-
$79.45
-
Number of holders
-
218
-
Value change
-
-$33,393,363
-
Number of buys
-
116
-
Number of sells
-
74
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2024
As of 30 Sep 2024,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,288,494 shares.
The largest 10 holders included
MORGAN STANLEY, Robeco Institutional Asset Management B.V., Royal Bank of Canada, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, BANK OF AMERICA CORP /DE/, and GOLDMAN SACHS GROUP INC.
This page lists
219
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.